Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: iTeos, Pandion And Aspen Show COVID-19 Hasn’t Slowed VC Deals Yet

Apr 01 2020

• By Mandy Jackson

Finance Watch

Related Content

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

Oct 23 2018

Finance Watch: Pandion's $55m Series A Funds Localized Bispecifics For Autoimmune Diseases

Jan 23 2018

Kallyope's Discovery Research Into The Gut-Brain Axis Advances

May 14 2019

Breath Therapeutics Snapped Up Post Series A By Specialty Company Zambon

Jul 25 2019

AM-Pharma Raises €116m To Finance Solo Phase III Trial

Jul 16 2019

Apexigen raises $20m for CD40-targeting immunotherapy

Aug 07 2013

Emergings In Brief, October 2014

Oct 29 2014

Deal Watch: Castle Creek Likes Partner Fibrocell Enough To Buy It

Sep 17 2019

Asia Deal Watch: Ambrx, NovoCodex Partner On Second ADC Candidate, For CD70-Positive Cancers

Nov 07 2019

At Paragon, Jeffrey Aronin Has Launched His Next Act – Or Eight Of Them

Jan 09 2020

ReCode Combines With TranscripTx, Raises $80m For Novel RNA Drugs

Mar 26 2020

Deal Watch: Coronavirus Collaborations Reflect Industry’s Full Press Pandemic Response

Mar 27 2020

Silverback Raises $78.5m To Test Localized Therapy Delivered Systemically In Patients

Mar 11 2020

AlloVir Gains PRIME Status For Anti-Virus T-Cell Therapy

Feb 13 2020

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Dec 17 2018

Finance Watch: Investments In Regenerative Therapies Surged In The Second Quarter

Aug 11 2018

Finance Watch: Pfizer Ventures' Dalton Makes Sense Of Neuroscience Focus Within New $600m VC Fund Commitment

Jun 13 2018

Deal Watch: Gilead Continues To Add To IO Armamentarium In Collaboration With Gadeta

Jul 20 2018

BIO Notebook, Day 3: Lilly Expands R&D Site, Sigilon Raises Cash And CytomX Talks Deal Strategy

Jun 22 2017

Deal Watch: GSK Furthers Cancer Gene Therapy Plans Via Lyell Collaboration

Oct 10 2019

Finance Watch: 3Q Biopharma Venture Capital Financings Fell From 2Q Spike

Oct 10 2019

Deal Watch: Merck Digging Into Epigenetics With Proteros Partnership

Dec 03 2016

ElevateBio Announces AlloVir As First Spoke In Its Cell And Gene Therapy Hub

May 23 2019

Pfizer’s 20-Valent Vaccine And Prevnar Successor Succeeds In Phase III

Mar 19 2020

Finance Watch: Biotech Stocks Down, But Holding Up Better Than Broader Indices

Mar 24 2020

Related Companies

iTeos Therapeutics Inc.

Pandion Therapeutics, Inc.

Astellas Pharma, Inc.

Silverback Therapeutics, Inc.

Breath Therapeutics Holding BV

Zambon Company S.p.A.

Ascendis Pharma A/S

uniQure N.V.

Ablynx N.V.

AlloVir, Inc.

Fred Hutchinson Cancer Research Center

Dragonfly Therapeutics, Inc.

Bristol Myers Squibb Company

Merck & Co., Inc.

AbbVie Inc.

Kallyope Inc.

Vaxcyte, Inc

Pfizer Inc.

Sigilon Therapeutics, Inc.

Eli Lilly and Company

Castle Creek Biosciences, Inc.

Paragon Biosciences LLC

Fibrocell Science, Inc.

Apexigen, Inc.

AM-Pharma B.V.

Additional Topics

Financing Business Strategies StartUps and SMEs Deals Innovation Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window